RIGEL PHARMACEUTICALS INC (RIGL) Stock Fundamental Analysis
USA - NASDAQ:RIGL - US7665597024 - Common Stock
35.11 USD
+0.89 (+2.6%)
35.8 USD
+0.69 (+1.97%)
Overall RIGL gets a fundamental rating of 6 out of 10. We evaluated RIGL against 540 industry peers in the Biotechnology industry. RIGL has an average financial health and profitability rating. RIGL has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make RIGL suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
In the past year RIGL was profitable.
In the past year RIGL had a positive cash flow from operations.
RIGL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: RIGL reported negative operating cash flow in multiple years.
1.2 Ratios
RIGL's Return On Assets of 47.32% is amongst the best of the industry. RIGL outperforms 99.63% of its industry peers.
RIGL's Return On Equity of 119.39% is amongst the best of the industry. RIGL outperforms 99.26% of its industry peers.
RIGL has a Return On Invested Capital of 68.80%. This is amongst the best in the industry. RIGL outperforms 99.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 47.32% | ||
| ROE | 119.39% | ||
| ROIC | 68.8% |
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of RIGL (36.51%) is better than 97.22% of its industry peers.
RIGL has a Operating Margin of 39.04%. This is amongst the best in the industry. RIGL outperforms 98.52% of its industry peers.
RIGL has a better Gross Margin (91.52%) than 92.22% of its industry peers.
RIGL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.04% | ||
| PM (TTM) | 36.51% | ||
| GM | 91.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
2. Health
2.1 Basic Checks
RIGL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
RIGL has more shares outstanding than it did 1 year ago.
RIGL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, RIGL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -2.50, we must say that RIGL is in the distress zone and has some risk of bankruptcy.
RIGL has a Altman-Z score of -2.50. This is comparable to the rest of the industry: RIGL outperforms 49.07% of its industry peers.
The Debt to FCF ratio of RIGL is 0.91, which is an excellent value as it means it would take RIGL, only 0.91 years of fcf income to pay off all of its debts.
RIGL's Debt to FCF ratio of 0.91 is amongst the best of the industry. RIGL outperforms 94.81% of its industry peers.
RIGL has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
RIGL's Debt to Equity ratio of 0.46 is on the low side compared to the rest of the industry. RIGL is outperformed by 72.22% of its industry peers.
Although RIGL does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 0.91 | ||
| Altman-Z | -2.5 |
ROIC/WACC6.94
WACC9.92%
2.3 Liquidity
RIGL has a Current Ratio of 2.02. This indicates that RIGL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.02, RIGL is doing worse than 74.07% of the companies in the same industry.
A Quick Ratio of 1.90 indicates that RIGL should not have too much problems paying its short term obligations.
RIGL's Quick ratio of 1.90 is on the low side compared to the rest of the industry. RIGL is outperformed by 74.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 729.07% over the past year.
Looking at the last year, RIGL shows a very strong growth in Revenue. The Revenue has grown by 105.62%.
The Revenue has been growing by 24.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)729.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5566.67%
Revenue 1Y (TTM)105.62%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%176.01%
3.2 Future
RIGL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.86% yearly.
The Revenue is expected to grow by 14.40% on average over the next years. This is quite good.
EPS Next Y503.1%
EPS Next 2Y102.44%
EPS Next 3Y61.96%
EPS Next 5Y29.86%
Revenue Next Year62.09%
Revenue Next 2Y26.39%
Revenue Next 3Y18.97%
Revenue Next 5Y14.4%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.49, which indicates a rather cheap valuation of RIGL.
Based on the Price/Earnings ratio, RIGL is valued cheaper than 97.41% of the companies in the same industry.
RIGL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 9.11, which indicates a very decent valuation of RIGL.
97.41% of the companies in the same industry are more expensive than RIGL, based on the Price/Forward Earnings ratio.
RIGL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.49 | ||
| Fwd PE | 9.11 |
4.2 Price Multiples
97.96% of the companies in the same industry are more expensive than RIGL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RIGL indicates a rather cheap valuation: RIGL is cheaper than 98.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.57 | ||
| EV/EBITDA | 4.77 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of RIGL may justify a higher PE ratio.
A more expensive valuation may be justified as RIGL's earnings are expected to grow with 61.96% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y102.44%
EPS Next 3Y61.96%
5. Dividend
5.1 Amount
RIGL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.11
+0.89 (+2.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners79.46%
Inst Owner Change-1.13%
Ins Owners2.59%
Ins Owner Change1.25%
Market Cap629.87M
Analysts76.67
Price Target39.1 (11.36%)
Short Float %11.49%
Short Ratio3.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)308.53%
Min EPS beat(2)24.64%
Max EPS beat(2)592.43%
EPS beat(4)4
Avg EPS beat(4)440.39%
Min EPS beat(4)24.64%
Max EPS beat(4)1076.54%
EPS beat(8)7
Avg EPS beat(8)241.24%
EPS beat(12)11
Avg EPS beat(12)177.31%
EPS beat(16)13
Avg EPS beat(16)133.23%
Revenue beat(2)2
Avg Revenue beat(2)15.63%
Min Revenue beat(2)12.08%
Max Revenue beat(2)19.17%
Revenue beat(4)4
Avg Revenue beat(4)17.43%
Min Revenue beat(4)9.15%
Max Revenue beat(4)29.32%
Revenue beat(8)7
Avg Revenue beat(8)9.33%
Revenue beat(12)10
Avg Revenue beat(12)13.36%
Revenue beat(16)11
Avg Revenue beat(16)9.9%
PT rev (1m)13.61%
PT rev (3m)13.61%
EPS NQ rev (1m)128.54%
EPS NQ rev (3m)307.02%
EPS NY rev (1m)380.48%
EPS NY rev (3m)394.78%
Revenue NQ rev (1m)7.38%
Revenue NQ rev (3m)22.41%
Revenue NY rev (1m)39.78%
Revenue NY rev (3m)39.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.49 | ||
| Fwd PE | 9.11 | ||
| P/S | 2.35 | ||
| P/FCF | 9.57 | ||
| P/OCF | 9.57 | ||
| P/B | 7.69 | ||
| P/tB | 11.25 | ||
| EV/EBITDA | 4.77 |
EPS(TTM)5.41
EY15.41%
EPS(NY)3.85
Fwd EY10.97%
FCF(TTM)3.67
FCFY10.44%
OCF(TTM)3.67
OCFY10.45%
SpS14.93
BVpS4.57
TBVpS3.12
PEG (NY)0.01
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 47.32% | ||
| ROE | 119.39% | ||
| ROCE | 87.08% | ||
| ROIC | 68.8% | ||
| ROICexc | 704.92% | ||
| ROICexgc | N/A | ||
| OM | 39.04% | ||
| PM (TTM) | 36.51% | ||
| GM | 91.52% | ||
| FCFM | 24.56% |
ROA(3y)-18.12%
ROA(5y)-18.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5Y-1.87%
F-Score6
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 0.91 | ||
| Debt/EBITDA | 0.35 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 15.13 | ||
| Cash Conversion | 61.51% | ||
| Profit Quality | 67.26% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | -2.5 |
F-Score6
WACC9.92%
ROIC/WACC6.94
Cap/Depr(3y)424.8%
Cap/Depr(5y)301.24%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)729.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5566.67%
EPS Next Y503.1%
EPS Next 2Y102.44%
EPS Next 3Y61.96%
EPS Next 5Y29.86%
Revenue 1Y (TTM)105.62%
Revenue growth 3Y6.31%
Revenue growth 5Y24.77%
Sales Q2Q%176.01%
Revenue Next Year62.09%
Revenue Next 2Y26.39%
Revenue Next 3Y18.97%
Revenue Next 5Y14.4%
EBIT growth 1Y1259.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year178.6%
EBIT Next 3Y76.86%
EBIT Next 5YN/A
FCF growth 1Y235.34%
FCF growth 3Y80.89%
FCF growth 5YN/A
OCF growth 1Y297.38%
OCF growth 3Y74.92%
OCF growth 5YN/A